<ARTICLE> 5 <LEGEND> This schedule contains summary financial information extracted from (a) Gelman Sciences Inc. Statement of Income and Consolidated Statement of Cash Flows for the three months ended October 31, 1995 an the Consolidated Balance Sheet as of October 31, 1995 and is qualified in its entirety by reference to such (b) Form 10-Q for the fist quarter ended October 31, 1995. </LEGEND> <CIK> 0000310252 <NAME> GELMAN SCIENCES INC. <MULTIPLIER> 1,000 <CURRENCY> US DOLLARS <PERIOD-TYPE> 3-MOS <FISCAL-YEAR-END> JUL-31-1996 <PERIOD-END> Oct-31-1995 <EXCHANGE-RATE> 1 <CASH> 3,292 <SECURITIES> 0 <RECEIVABLES> 26,154 <ALLOWANCES> 1,364 <INVENTORY> 13,792 <CURRENT-ASSETS> 47,156 <PP&E> 71,310 <DEPRECIATION> 38,358 <TOTAL-ASSETS> 82,401 <CURRENT-LIABILITIES> 14,129 <BONDS> 7,369 <COMMON> 782 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <OTHER-SE> 60,121 <TOTAL-LIABILITY-AND-EQUITY> 82,401 <SALES> 27,335 <TOTAL-REVENUES> 27,335 <CGS> 13,493 <TOTAL-COSTS> 13,493 <OTHER-EXPENSES> 10,702 <LOSS-PROVISION> 76 <INTEREST-EXPENSE> 154 <INCOME-PRETAX> 2,910 <INCOME-TAX> 988 <INCOME-CONTINUING> 1,922 <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> 1,922 <EPS-PRIMARY> 0.24 <EPS-DILUTED> 0.24